The six-minute walk test (6MWT) provides a reliable way to measure exercise capacity in patients with moderate to severe pulmonary diseases, helping clinicians track functional status and guide treatment decisions. Unlike pulmonary function tests, the 6MWT captures the often-coexisting extrapulmonary manifestations of chronic respiratory diseases, including cardiovascular diseases, frailty, sarcopenia, and cancer.
Because it is simple, inexpensive, and safe, the six-minute walk test is an indispensable tool in clinical practice. Below, we explain how the six-minute walk test works, review the ATS guidelines, and highlight its key clinical applications.
By América Torres
What Is the Six-Minute Walk Test?
The six-minute walk test is a low-complexity and safe assessment that does not require the specialized equipment or maximal-effort conditions needed in cardiopulmonary exercise testing. The clinician simply instructs the patient to walk as far as possible along a flat, straight 30-meter corridor for a period of 6 minutes (six-minute walk distance or 6MWD). The absolute distance in the 6MWT and changes in it are predictive of morbidity and mortality in patients with COPD, pulmonary arterial hypertension, pulmonary fibrosis, and other conditions. This demonstrates the value of the test’s results in guiding clinical management decisions.
How to Perform the Six-Minute Walk Test
As the name suggests, the goal of the six-minute walk test is for patients to walk as far as possible for 6 minutes. Clinicians conduct the test indoors, on a 30-meter long, flat, straight corridor with a firm, low-traffic surface. Clinicians mark a starting line to indicate the beginning and end of each 60-meter lap. They also mark the corridor every 3 meters and place a cone at each turnaround point (such as an orange traffic cone). In general, the test protocol requires attention to the following points:
- Â Advise patients to wear comfortable clothing and appropriate walking shoes. Additionally, they should use their usual walking aids during the test (such as a cane or walker), if applicable.
- They should not have engaged in intense exercise in the 2 hours prior to the test. However, a light meal is acceptable before tests conducted early in the morning or early in the afternoon.
- Tell patients to continue their usual medical regimen.
- Patients should use their prescribed oxygen therapy and manage their oxygen delivery device. IIf this is not possible, the assessor walks slightly behind the patient to avoid setting the pace.
- It is important to record how patients receive oxygen support, and perform all subsequent tests in the same manner.
- Oxygen should not be adjusted during the study, as supplemental oxygen and its portability affect exercise performance, and the distance walked.
- Patients should rest for at least 10 minutes before starting the test.
- Document blood pressure, heart rate, SpO2, and baseline levels of dyspnea and fatigue during this time.
ATS Guidelines for the Six-Minute Walk Test
In 2002, the American Thoracic Society published its Clinical Practice Guidelines for the 6-Minute Walk Test. This document details the factors influencing the results, provides a brief step-by-step protocol for performing the test, describes the safety measures, proper patient preparation and procedures, and offers guidelines for interpreting the results. Among the most notable information contained in this document, we can mention:
Indications for the Test. The strongest indication for the 6MWT is to measure the response to medical interventions in patients with moderate to severe cardiac or pulmonary diseases. However, it also serves as a predictor of morbidity and mortality in patients.
Contraindications: Absolute contraindications include unstable angina within the previous month and myocardial infarction within the previous month. Relative contraindications include a resting heart rate of more than 120, a systolic blood pressure of more than 180 mm Hg, and a diastolic blood pressure of more than 100 mm Hg.
Additional ATS Best Practices for Test Consistency
- Perform repeated tests at approximately the same time of day to minimize intraday variability.
- Patients should not perform a warm-up period before the test.
- Patients sit at rest in a chair located near the starting point for at least 10 minutes before the test begins.
Clinical Applications of the Six-Minute Walk Test
Now that we have briefly discussed how to perform the test and the ATS guidelines that ensure patient safety, we can shift the focus. Let’s turn our attention to several of its most significant clinical advantages.
Six-Minute Walk Test in COPD
There is a strong correlation between the distance walked in the 6-minute walk test and clinical outcomes in patients with COPD. This is likely because the test captures both pulmonary and extrapulmonary manifestations of the disease. In fact, comorbidities are likely responsible for more than 50% of deaths in patients with COPD.
A study on longitudinal changes in the 6-minute walk distance in 198 patients with severe COPD, over a 2-year period, found increased survival with increments in 6MWD when divided into discrete 100-meter increments.
On the other hand, in a prospective observational study of 2,110 patients with clinically stable COPD in stages II to IV, according to the Global Initiative for Chronic Obstructive Lung Disease, where 6-minute walk tests (6MWT) were performed at baseline and annually, the 6MWD thresholds with the highest sensitivity and specificity for hospitalization or 3-year mortality were 357 and 334 meters, respectively.
Six-Minute Walk Test in Idiopathic Pulmonary Fibrosis
The 6-minute walk test is a useful predictor of outcomes in numerous clinical settings for patients with idiopathic pulmonary fibrosis (IPF). In a prospective observational study of patients newly diagnosed with IPF, a 6MWD ≤ 72% of the predicted value was a significant independent predictor of mortality, with a hazard ratio of 3.27. When added to a composite physiological index (calculated based on the extent of disease on CT scan, diffusing capacity of the lung for carbon monoxide [DLCO], FVC, and FEV1) and the Medical Research Council dyspnea scale score, the test was able to predict 3-year mortality with 100% specificity.
Six-Minute Walk Test and Lung Transplant Evaluation
Before 2005, lung allocation largely depended on the time a patient had been on the waiting list, regardless of disease severity. In 2005, a new allocation system was implemented to seek a more equitable distribution of organs. The lung allocation score is a 0 to 100 scale that uses predictive criteria for both waitlist mortality and post-transplant mortality. The 6-minute walk test (6MWT) has been incorporated into the scoring system as a dichotomous variable (above or below 150 feet [45.7 meters]). However, there is ongoing controversy regarding the appropriate threshold or whether it is preferable to use it as a continuous variable.
A Simple Way to Perform the Six-Minute Walk Test in Daily Practice
The 6-minute walk test is a reliable measure of functional capacity, which is also simple to perform and interpret. The distance walked in 6 minutes is a predictor of mortality across a wide range of chronic respiratory conditions. The six-minute walk test is simple, but workflows benefit from tools that streamline documentation and data capture.
How the DS-20 Diagnostic Station Supports the Six-Minute Walk Test
SCHILLER offers an easy-to-use solution that further simplifies the execution of this test. The DS-20 diagnostic station delivers a unique, all-in-one solution that combines vital-sign and essential physical-assessment tools, such as:
NIBP
Temperature
SpOâ‚‚
3-lead ECG
12-lead ECG
In addition to these features, it also includes the capability to perform the 6-minute walk test.
The DS-20 diagnostic station is very easy to use, allowing you to perform all tests quickly and streamline triage:
- Quickly evaluate all vital signs and tests in a single area, avoiding room-to-room transfers.
- View all information on the large touchscreen of the DS-20.
- Store studies on your PC via Wi-Fi, LAN, or Ethernet.
- Use the barcode reader to avoid data entry errors.
It only takes a few minutes to discover the practical advantages of the DS-20 diagnostic station. Experience these benefits in a no-cost, no-obligation in-person or remote demonstration.
REFERENCES
Priya Agarwala, Steve H. Salzman. Six-Minute Walk Test. Chest. 2020 Mar; 157(3): 603–611. Published online 2019 Nov 2. doi: 10.1016/j.chest.2019.10.014
ATS Statement Guidelines for the Six-Minute Walk Test. https://www.atsjournals.org/doi/full/10.1164/ajrccm.166.1.at1102
Â
Key Questions About the 6-Minute Walk Test
What is the purpose of the 6-minute walk test and how is it performed?
The 6-minute walk test (6MWT) measures a patient’s functional exercise capacity by assessing the distance they can walk in six minutes along a straight, flat 30-meter corridor. It reflects the integrated response of the pulmonary, cardiovascular, circulatory, and neuromuscular systems. Because it is simple, low-risk, and inexpensive, it is often used to evaluate baseline capacity, monitor disease progression, and assess response to therapy.
What clinical conditions can be evaluated using the 6-minute walk test?
The 6MWT is particularly useful for patients with chronic respiratory diseases such as COPD, pulmonary arterial hypertension, pulmonary fibrosis, cystic fibrosis, and interstitial lung disease. It is also valuable for assessing functional limitation in cardiac diseases, frailty, sarcopenia, and conditions where extrapulmonary manifestations influence exercise performance.
What do ATS guidelines recommend for conducting the 6-minute walk test safely?
The American Thoracic Society (ATS) guidelines specify standardized procedures to ensure consistency and safety. Key recommendations include conducting the test in a 30-meter corridor, maintaining a controlled indoor environment, using consistent oxygen supplementation protocols, avoiding warm-up sessions, and allowing at least 10 minutes of seated rest before starting the test.
How is the 6-minute walk distance used to predict morbidity and mortality?
The 6-minute walk distance (6MWD) is a strong prognostic marker in multiple diseases. Shorter distances and significant declines over time correlate with higher mortality, hospitalizations, and disease progression. In COPD, pulmonary hypertension, and pulmonary fibrosis, specific thresholds—such as 334 to 357 meters in COPD—are associated with increased risk.
Why is the 6MWT an important tool for patients with COPD, pulmonary hypertension, or pulmonary fibrosis?
These conditions involve both pulmonary and extrapulmonary impairments. Because the 6MWT captures the combined effect of cardiovascular function, muscle strength, and overall conditioning, it reveals limitations that may not be detected through pulmonary function tests alone. It also helps guide therapy and assess response to treatment.